---
schema_version: "secwatch.filing_event.v1"
accession: "0001663577-23-000139"
form_type: "8-K"
ticker: "MDNC"
cik: "0001931055"
company_name: "Medinotec Inc."
filed_at: "2023-03-31T23:59:59+00:00"
generated_at: "2026-06-17T08:34:33.111613+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Medinotec Inc. approved to trade on OTCQX Best Market under symbol MDNC

## Summary
- OTC Markets notified Medinotec on March 30, 2023; trading on OTCQX began March 31, 2023.
- Company qualifies for OTCQX by meeting high financial standards and corporate governance requirements.
- B. Riley Securities acted as OTCQX sponsor for the upgrade.
- CEO Gregory Vizirgianakis cited increased exposure and commitment to shareholder value.
- Medinotec plans to expand US sales, initially focusing on its Trachealtor device (2021 MDEA gold winner).

## SEC filing metadata
- accession: 0001663577-23-000139
- form_type: 8-K
- ticker: MDNC
- cik: 0001931055
- company_name: Medinotec Inc.
- filed_at: 2023-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1931055/000166357723000139/0001663577-23-000139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1931055/000166357723000139/mdnc8k033123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001663577-23-000139
- JSON: https://secwatch.observer/filing/0001663577-23-000139.json
- Plain text: https://secwatch.observer/filing/0001663577-23-000139.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.